© 2022 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Experts discuss collaboration between ophthalmologists and optometrists in the management of patients with retinal eye disease.
March 15th 2022
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss the co-management of retinal eye disorders and provide a clinical overview of the disease.
Experts discuss the challenges regarding the treatment of retinal disorders, and how co-management can potentially address those challenges.
March 22nd 2022
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss the American Academy of Ophthalmology (AAO) guidelines on co-management between optometrists and ophthalmologists in retinal eye disorders.
Experts in the field of retinal eye disorders talk about the role of ophthalmologists and optometrists in regard to patient education and communication.
March 29th 2022
Experts in the field of retinal eye disorders discuss how the COVID-19 pandemic and use of telemedicine has affected communication between optometrists, ophthalmologists, patients, and providers.
A. Paul Chous, MA, OD, FAAO, leads a discussion about the optimal circumstances for optometrists and ophthalmologists to work together to manage a patient with retinal eye disorders.
April 5th 2022
Key opinion leaders discuss how co-management affects the patient-provider relationship in the treatment of retinal eye disorders.
Dilsher S. Dhoot, MD, leads a discussion about the treatment landscape of retinal eye disorders.
April 12th 2022
Experts in the field of retinal eye disorders discuss the role of injectable anti-VEGF inhibitors and how they have changed the treatment landscape.
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss the transition of care from ophthalmologist to optometrist once a patient has completed active treatment for retinal eye disease.
Commercial real estate and your practice, part two with Colin Carr
Cleveland Clinic breaks ground on expansion of Cole Eye Institute
The sword and shield of investing